Nivolumab for advanced non-squamous non-small-cell lung cancer after chemotherapy
Technology appraisal guidance
Reference number: TA713
Published:
This appraisal topic is paused to allow the company to provide updated submission documentation. The appraisal will be rescheduled into the work programme and the updated appraisal timelines will be communicated, once known.